
































Predictors of Long-Term Pain After Hip Arthroplasty in
Patients With Femoral Neck Fractures: A Cohort Study
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Objectives: To identify factors associated with the development of
prolonged pain after hip fracture surgery.
Design: Secondary analysis of a randomized controlled trial.
Setting: Eighty hospitals in 10 countries.
Patients/Participants: One thousand four hundred forty-one hip
fracture patients in the HEALTH trial.
Interventions: Total hip arthroplasty or hemiarthroplasty.
Main Outcome Measures: Moderate-to-severe pain (at least 2
activities on the Western Ontario and McMaster Universities
Osteoarthritis questionnaire pain subscale with scores $2) at 12
and 24 months after hip arthroplasty.
Results: Of 840 and 726 patients with complete baseline data and
outcomes at 1-year and 2-year follow-up, 96 (11.4%) and 80
(11.0%) reported moderate-to-severe pain, respectively. An
increased risk of pain at both 1 and 2 years after surgery was
associated with reporting moderate-to-severe hip pain before
fracture [absolute risk increase (ARI) 15.3%, 95% confidence
interval (CI) 6.44%–24.35%; ARI 12.5%, 95% CI 2.85%–22.12%,
respectively] and prefracture opioid use (ARI 15.6%, 95% CI
5.41%–25.89%; ARI 21.1%; 95% CI 8.23%–34.02%, respec-
tively). Female sex was associated with an increased risk of per-
sistent pain at 1 year (ARI 6.2%, 95% CI 3.53%–8.84%). A
greater risk of persistent pain at 2 years was associated with youn-
ger age (#79-year-old; ARI 6.3%; 95% CI 2.67%–9.91%)
and higher prefacture functional status (ARI 10.7%; 95% CI
3.80%–17.64%).
Conclusions: Among hip fracture patients undergoing arthro-
plasty, approximately one in 10 will experience moderate-to-severe
pain up to 2 years after surgery. Younger age, female sex, higher
functioning prefracture, living with hip pain prefracture, and use of
prescription opioids were predictive of persistent pain.
Key Words: hip arthroplasty, hemiarthroplasty, femoral neck frac-
ture, predictors, pain
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INTRODUCTION
Hip fracture is a severe and frequent event affecting a
large number of older adults around the world.1
Approximately 52,000 hip fracture–related hospital admis-
sions were reported among the population aged 80 years and
older between 2011 and 2015 in Ontario, Canada, alone.2 Hip
fractures are associated with impaired mobility, loss of quality
of life, and one-year mortality rate estimations between 14%
and 58% after injury.3–7
Displaced femoral neck fractures are common injuries,
which are often managed with arthroplasty, especially for
patients $80 years.8 With an aging population globally, the
demands for arthroplasty are predicted to increase
substantially.9 Although symptom relief is an important
goal of hip arthroplasty, many patients experience persistent
postsurgical pain.10 For instance, one study of patients with a
displaced subcapital hip fracture found that 13% reported
moderate-to-severe persistent pain at one year after the
surgery.11 Some evidence suggests that total hip
arthroplasty (THA) may provide better long-term pain relief
than hemiarthroplasty12; however, the HEALTH randomized
controlled trial results did not find a benefit of THA over
hemiarthroplasty in reducing persistent pain.13 Improved
understanding of factors associated with long-term pain
after hip arthroplasty could facilitate targeting of high-risk
patients in an effort to improve prognosis.
In this study, we aimed to investigate which factors
(modifiable and nonmodifiable) are associated with moderate-
to-severe pain at 12 and 24 months after hip arthroplasty in




This study used data from 1441 participants enrolled in
the HEALTH trial, a randomized controlled trial that explored
the effect of THA or hemiarthroplasty for patients $50 years
with a displaced femoral neck fracture.13
Outcome Measure
In the HEALTH trial, the Western Ontario and
McMaster Universities Osteoarthritis (WOMAC) question-
naire was administered to assess hip-related pain status of
patients before their fracture occurred (completed at time of
study enrollment) and at 12 months and 24 months after
surgery. The WOMAC has been shown to be valid, reliable,
responsive, and feasible in hip fracture patients.14 The ques-
tionnaire contains 5 different activity questions for pain inten-
sity assessment with options of “no,” “mild,” “moderate,”
“severe,” and “extreme” pain. We summed these scores for
all 5 questions and calculated the overall pain score (range 0–
20) for each patient. In keeping with previous studies, we
defined our outcome as the presence of moderate-to-severe
pain (a score of 2 or more for at least 2 questions on activities
using the WOMAC pain subscale) or no moderate-to-severe
pain (a score of 0 or 1 for at least 3 items on activities, which
we used as the reference group in our analysis) at 12 and 24
months after hip surgery.15–17
Predictors
The first group of predictors consisted of demographic
variables, including age (#79 vs. .79 years. 79 was the
median age of all included participants) and sex (women vs.
men). We also considered prefracture variables including
those reporting moderate-to-severe hip pain before the occur-
rence of the fracture (yes vs. no), use of opioid medications
before fracture (yes vs. no), prefracture functional status (am-
bulating without assistance vs. use of an assistive device),
prefracture living status (institutionalized vs. noninstitutional-
ized), previous surgery affecting hip (yes vs. no), having
major comorbidities including back pain, osteoarthritis, can-
cer, rheumatoid arthritis, and depression (yes vs. no), body
mass index (BMI, 25–34.9 kg/m2 vs. #24.9 kg/m2), and the
American Society of Anesthesiologists (ASA) classification
(III/IV/V vs. I/II). In addition, procedure-related factors,
including type of arthroplasty surgery (THA vs. bipolar or
unipolar hemiarthroplasty) and type of surgical approach
(anterolateral/direct anterior vs. posterior/posterolateral), were
included. We also considered 4 postoperative variables, all of
which were measured up to 30 days after surgery, including
patient’s weight-bearing status (non/partial vs. full), use of
any physiotherapy or rehabilitation (yes vs. no), serious
adverse events (yes vs. no), and fracture-related complica-
tions (complication with or without revision surgery vs. no
complication). We chose 30 days after surgery as our cut-off
mark to avoid concerns regarding the temporality of the pre-
dictors and the study outcomes.
Statistical Analysis
We reported the mean and SD of continuous variables,
and absolute and relative frequencies for categorical vari-
ables. We used logistic regression analyses to determine
predictors of moderate-to-severe pain at 12 and 24 months
after hip fracture repair. We excluded patients from our
analyses if their pain score, measured using the WOMAC,
before fracture and at follow-up times (12 and 24 months),
were unavailable. We first ran univariable models to estimate
the unadjusted odds ratios (ORs), then we constructed
multivariable models for both visits. We selected 12 inde-
pendent factors for multivariable models previously reported
as important predictors18 or variables judged to be associated
with persistent pain by experts, including age, sex, BMI,
prefracture moderate-to-severe hip pain, opioid use, func-
tional status, depression, weight-bearing status, use of any
physiotherapy or rehabilitation, and serious adverse events.
We also adjusted for the type of arthroplasty surgery and
surgical approach that were used in the HEALTH trial. We
excluded independent variables with fewer than 50 observa-
tions per category, unless we were able to collapse them with
other related variables to exceed this threshold (Table 1). We
then applied the Hosmer–Lemeshow (H-L) goodness of fit
test for these adjusted models19 and reported the statistics.
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TABLE 1. Demographics and Clinical Characteristics at 12- and 24-Month Follow-up Visits in Patients With Femoral Neck
Fractures
Characteristics




Severe Pain, n = 744
Moderate-to-Severe




Severe Pain, n = 646
Moderate-to-Severe





399 (47.5) 346 (86.7) 53 (13.3) 362 (49.9) 315 (87.0) 47 (13.0)
Above median
(.79 years)
441 (52.5) 398 (90.2) 43 (9.8) 364 (50.1) 331 (91.0) 33 (9.0)
Sex, n (%)
Female 618 (73.6) 538 (87.0) 80 (13.0) 546 (75.0) 484 (88.6) 62 (11.3)
Male 222 (26.4) 206 (92.8) 16 (7.2) 180 (25.0) 162 (90.0) 18 (10.0)
Preoperative factors
BMI, n (%)
#24.9 431 (52.0) 384 (89.1) 47 (10.9) 368 (51.0) 332 (90.0) 36 (10.0)




No 696 (89.7) 631 (90.7) 65 (9.3) 605 (90.7) 552 (91.2) 53 (8.8)
Yes 80 (10.3) 60 (75.0) 20 (25.0) 62 (9.3) 45 (72.6) 17 (27.4)
Prefracture opioid use,
n (%)
No 774 (92.1) 695 (89.8) 79 (10.2) 670 (92.2) 607 (90.6) 63 (9.4)





673 (80.1) 603 (89.6) 70 (10.4) 589 (81.1) 535 (91) 54 (9)
Ambulate without
assistance
167 (19.9) 141 (84.4) 26 (15.6) 137 (18.8) 111 (81) 26 (19)
Prefracture living
status, n (%)†
Not institutionalized 822 (97.9) 731 (89.0) 91 (11.0) 717 (98.7) 639 (89.1) 78 (10.8)
Institutionalized 18 (2.1) 13 (72.2) 5 (27.8) 9 (1.2) 7 (77.7) 2 (22.2)
Previous surgery to
affected hip n (%)†
No 836 (99.6) 740 (88.5) 96 (11.5) 723 (99.7) 644 (89.0) 79 (10.9)
Yes 3 (0.4) 3 (100) 0 (0) 2 (0.28) 1 (50.0) 1 (50.0)
ASA class, n (%)
I/II 416 (49.5) 370 (89.0) 46 (11.0) 389 (53.5) 354 (91) 35 (9)





No 817 (97.3) 725 (88.8) 92 (11.2) 704 (96.9) 627 (89) 77 (11)
Yes 23 (2.7) 19 (82.6) 4 (17.4) 22 (3.0) 19 (86) 3 (14)
Osteoarthritis, n (%)
No 714 (85) 643 (90.0) 71 (10.0) 623 (85.8) 556 (90) 67 (10)
Yes 126 (15) 101 (80.1) 25 (19.9) 103 (14.1) 90 (87) 13 (13)
Cancer, n (%)
No 757 (90.1) 674 (89.0) 83 (11.0) 654 (90.0) 583 (89) 71 (11)
Yes 83 (9.9) 70 (84.3) 13 (15.7) 72 (9.9) 63 (87.5) 9 (12.5)
(continued on next page )
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We assessed the impact of influential observations by
calculating the deviance residual and explored for multi-
collinearity among the independent variables using the
variance inflation factor, with values greater than 5 indicating
a possible issue regarding collinearity.20 Discriminability of
the models was checked using the area under the curve
statistic, with values between 0.7 and 0.8 indicating accept-
able classification performance of a model. We reported
adjusted ORs (aORs) along with their 95% confidence inter-
vals (95% CIs). In addition, we reported the absolute risk
increase (ARI) for each significant predictor in the selected
adjusted models by estimating the baseline risk of outcome
TABLE 1. (Continued ) Demographics and Clinical Characteristics at 12- and 24-Month Follow-up Visits in Patients With Femoral
Neck Fractures
Characteristics




Severe Pain, n = 744
Moderate-to-Severe




Severe Pain, n = 646
Moderate-to-Severe
Pain, n = 80
Depression, n (%)
No 738 (87.9) 658 (89.1) 80 (10.9) 639 (88.0) 570 (89) 69 (11)
Yes 102 (12.1) 86 (84.0) 16 (16.0) 87 (11.9) 76 (87) 11 (13)
Back pain, n (%)
No 759 (90.3) 679 (89.4) 80 (10.6) 655 (90.2) 594 (91) 61 (9)






315 (37.5) 284 (90.1) 31 (9.9) 280 (38.6) 249 (89) 31 (11)
Anterolateral/direct
anterior
524 (62.46) 459 (87.6) 65 (12.4) 446 (61.4) 397 (89) 49 (11)
Surgery type, n (%)
THA 414 (49.4) 372 (89.9) 42 (10.1) 363 (50.0) 331 (91.2) 32 (8.8)
Bipolar
hemiarthroplasty
212 (25.3) 186 (87.8) 26 (12.2) 189 (26.0) 164 (86.8) 25 (13.2)
Unipolar
hemiarthroplasty




Non or partial 355 (42.2) 317 (89.3) 38 (10.7) 295 (40.7) 258 (87.4) 37 (12.6)




No 61 (7.3) 51 (83.6) 10 (16.4) 53 (7.3) 44 (83.0) 9 (17.0)
Yes 774 (92.7) 690 (89.1) 84 (10.9) 669 (92.7) 599 (89.5) 70 (10.5)
Serious adverse events,
n (%)§
No 672 (80.0) 596 (88.7) 76 (11.3) 594 (81.8) 530 (89.2) 64 (10.8)








29 (3.4) 27 (93.1) 2 (6.9) 22 (3.0) 19 (86.4) 3 (13.6)
Complication with
revision surgery
37 (4.4) 31 (83.8) 6 (16.2) 31 (4.3) 27 (87.1) 4 (12.9)
*The WOMAC questionnaire was administered and asked patients to indicate the severity of hip pain before their fracture occurred.
†Variables with very low frequency in one subcategory were not included in the regression models.
‡These variables were collected immediately after surgery.
§These variables were collected within 30 days after surgery.
ASA, American Society of Anesthesiologists; BMI, body mass index; THA, total hip arthroplasty.
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(for both 12- and 24-month follow-up) among patients who
did not have any significant risk factors. We also tested for an
interaction between opioid use and functional status, hypoth-
esizing that patients who used opioids and used assistive
devices to ambulate before fracture may be more likely to
experience moderate-to-severe persistent pain. Variables with
P values less than 0.05 in the adjusted models were consid-
ered statistically significant. All analyses were performed in
Stata version 15.
RESULTS
At 12- and 24-month follow-up visits, 1127 and 1122
patients, respectively, were eligible for our study. At the 1-
year follow-up visit, 64 (5.7%) and by 2 years postopera-
tively, 113 (10%) participants had died. Of the 1063 and 1009
patients who were alive, 840 (20% missing data) and 726
(28% missing data) had follow-up data available for the
analysis of pain at 12 and 24 months follow-up, respectively.
Details regarding participant flow and the reasons for
exclusion are provided in Fig. 1.
Patient Characteristics
At the 12-month follow-up visit, 96 of the 840 patients
(11.4%) and at 24 months, 80 of the 726 patients (11.0%)
reported moderate-to-severe pain. Patients had a median age
of 79 years, most were women (73.0% at 12 months and
75.0% at 24 months), not institutionalized (approximately
98.0% at both visits) before the fracture occurred and did not
have a previous surgery affecting the hip (.99.0%).
Demographic, preoperative/prefracture factors, comorbidities,
procedure related, and postoperative characteristics among
patients with and without moderate-to-severe pain are pre-
sented in Table 1.
Multivariable Logistic Model at 12-Month
Follow-Up Visit
Among 165 patients without identified risk factors for
pain (significant predictors in the adjusted model that reduced
the risk of moderate-to-severe pain at 12-month visit), 8
reported moderate-to-severe pain at 1 year for a baseline risk
of 4.8%. In the adjusted model (Table 2), female patients (OR
1.85; 95% CI 1.0–3.45; ARI 6.2%, 95% CI 3.53%–8.84%;
FIGURE 1. Cohort of patients’ selection
flow.
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P = 0.049), patients with prefracture hip pain (OR 2.68; 95%
CI 1.46–4.90; ARI 15.4%, 95% CI 6.44%–24.35%; P =
0.001), and opioid use (OR 2.66; 95% CI 1.35–5.24; ARI
15.7%, 95% CI 5.41%–25.90%; P = 0.005) had a signifi-
cantly higher risk of experiencing moderate-to-severe pain
at 1-year after surgery (Table 2).
Multivariable Logistic Model at 24-Month
Follow-Up Visit
Among 218 patients without identified risk factors for
pain (significant predictors in the adjusted model that reduced
the risk of moderate-to-severe pain at 24-months visit), 11
reported moderate-to-severe pain at 2 years for a baseline risk
of 5.05%. Patients with prefracture hip pain (OR 2.52; 95%
CI 1.25–5.06; ARI 12.5%, 95% CI 2.85%–22.12%; P =
0.01), prefracture opioid use (OR 4.32; 95% CI 2.08–8.95;
ARI 21.1%; 95% CI 8.23%–34.02%; P , 0.001), aged #79-
year-old (OR 1.92; 95% CI 1.09–3.39; ARI 6.3%; 95% CI
2.67%–9.91%; P = 0.025), and who ambulated without assis-
tive devices before surgery (OR 2.38; 95% CI 1.28–4.44; ARI
10.7%; 95% CI 3.80%–17.64%; P = 0.006) were more likely
to report moderate-to-severe pain after 2 years (Table 3).
The interaction between prefracture opioid use and
functional status was not statistically significant (P = 0.32).
TABLE 2. Factors Associated With Moderate-to-Severe Pain (vs. Mild or No Pain) at 12 Months in Patients With Femoral Neck
Fractures
Factor Unadjusted OR (95% CI) P Adjusted OR (95% CI) P ARI %(95% CI)
Age
Above median (.79 years) Reference Reference
Below median (#79 years) 1.41 (0.92–2.17) 0.109 1.42 (0.86–2.32) 0.167 —
Sex
Male Reference Reference
Female 1.91 (1.09–3.35) 0.023 1.85 (1.0–3.45) 0.049 6.2 (3.53–8.84)
BMI
#24.9 Reference — Reference
25–34.9 1.09 (0.71–1.67) 0.691 0.96 (0.6–1.55) 0.874 —
Prefracture moderate-to-severe hip
pain
No Reference — Reference
Yes 3.23 (1.83–5.70) ,0.001 2.68 (1.46–4.90) 0.001 15.4 (6.44–24.35)
Prefracture opioid use
No Reference — Reference
Yes 3.05 (1.67–5.55) ,0.001 2.66 (1.35–5.24) 0.005 15.7 (5.41–25.90)
Prefracture functional status
Uses an assistive device Reference — Reference
Ambulate without assistance 1.58 (0.97–2.58) 0.062 1.52 (0.86–2.67) 0.147 —
Depression
No Reference Reference
Yes 1.53 (0.85–2.73) 0.152 1.19 (0.6–2.33) 0.62 —
Surgical approach
Posterior/posterolateral Reference — Reference
Anterolateral/direct anterior 1.29 (0.82–2.04) 0.260 1.1 (0.64–1.89) 0.722 —
Surgery type
THA Reference — Reference
Bipolar hemiarthroplasty 1.24 (0.74–2.08) 0.421 1.05 (0.59–1.87) 0.858 —
Unipolar hemiarthroplasty 1.35 (0.81–2.24) 0.251 1.35 (0.74–2.43) 0.325 —
Weight-bearing status
Full Reference — Reference
Non or partial 0.88 (0.57–1.36) 0.573 0.94 (0.57–1.57) 0.826 —
Early physiotherapy or rehabilitation
No Reference — Reference
Yes 0.62 (0.30–1.26) 0.191 0.9 (0.39–2.07) 0.809 —
Serious adverse events
No Reference — Reference
Yes 1.05 (0.62–1.79) 0.828 0.76 (0.4–1.43) 0.388 —
Adjusted model: the Hosmer–Lemeshow (HL) test P value: 0.833; C-statistics: 0.67.
AR, absolute risk increase; BMI, body mass index; OR, odds ratio; THA, total hip arthroplasty.
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We did not find any variables with a variance inflation factor
greater than 1.50, and no variables had a deviance residual
more than 3, which may suggest no evidence of serious multi-
collinearity or influential observations in our data.
DISCUSSION
We found that approximately one in 10 hip fracture
patients experienced moderate-to-severe pain 2 years after
arthroplasty. Younger age, female sex, higher functioning
before fracture, living with hip pain, and use of prescription
opioids were predictive of persistent pain after surgery.
In our adjusted analyses, patients reporting pain and use
of opioids before their fracture occurred were more than twice
as likely to report persistent moderate-to-severe pain after hip
surgery, which is consistent with findings of other studies
exploring prognosis after THA and total knee arthro-
plasty.21,22 Evidence suggests that chronic use of opioids
may produce opioid-induced hyperalgesia,23 which can result
in pain sensitivity and in developing persistent pain after
surgery.24,25 In addition, opioids are commonly prescribed
for chronic pain; pre-existing pain in another part of the body
may influence pain severity of replaced joints.26,27 As such,
there is a possibility that patients reported persistent
TABLE 3. Factors Associated With Moderate-to-Severe Pain (vs. Mild or No Pain) at 24 Months in Patients With Femoral Neck
Fractures
Factor Unadjusted OR (95% CI) P Adjusted OR (95% CI) P ARI % (95% CI)
Age
Above median (.79 years) Reference Reference
Below median (#79 years) 1.49 (0.93–2.39) 0.093 1.92 (1.09–3.39) 0.025 6.2 (2.67–9.90)
Sex
Male Reference Reference
Female 1.15 (0.66–2.00) 0.615 1.20 (0.63–2.28) 0.561 —
BMI
#24.9 Reference Reference




Yes 3.93 (2.11–7.35) ,0.001 2.52 (1.25–5.06) 0.01 12.4 (2.85–22.11)
Prefracture opioid use
No Reference Reference
Yes 4.20 (2.25–7.85) ,0.001 4.32 (2.08–8.95) ,0.001 21.1 (8.22–34.02)
Prefracture functional status
Uses an assistive device Reference Reference
Ambulate without assistance 2.32 (1.39–3.87) 0.001 2.38 (1.28–4.44) 0.006 10.7 (3.80–17.63)
Depression
No Reference Reference
Yes 1.20 (0.61–2.36) 0.606 0.91 (0.41–1.99) 0.807 —
Surgical approach
Posterior/posterolateral Reference Reference
Anterolateral/direct anterior 0.99 (0.61–1.59) 0.972 0.88 (0.49–1.58) 0.658 —
Surgery type
THA Reference Reference
Bipolar hemiarthroplasty 1.58 (0.90–2.75) 0.108 1.42 (0.76–2.66) 0.27 —
Unipolar hemiarthroplasty 1.59 (0.89–2.80) 0.112 1.97 (1–3.88) 0.052 —
Weight-bearing status
Full Reference Reference
Non or partial 1.29 (0.81–2.06) 0.279 1.50 (0.85–2.64) 0.161 —
Early physiotherapy or rehabilitation
No Reference Reference
Yes 0.57 (0.26–1.21) 0.148 0.79 (0.32–1.96) 0.609 —
Serious adverse events
No Reference Reference
Yes 1.14 (0.63–2.04) 0.655 1.06 (0.54–2.08) 0.87 —
Adjusted model: the Hosmer–Lemeshow (HL) test P value: 0.229; C-statistics: 0.71.
AR, absolute risk increase; BMI, body mass index; OR, odds ratio; THA, total hip arthroplasty.
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moderate-to-severe pain after surgery because of an underly-
ing chronic pain condition.28
Our results did not indicate that surgery type (eg, THA
vs. bipolar or unipolar hemiarthroplasty) is a significant
predictor of pain at 1 and 2 years after surgery. We also
found no association between receiving early physiotherapy/
rehabilitation or weight-bearing status and pain at 12- and 24-
month follow-up. Consistent with our findings, a retrospec-
tive study did not find a significant difference between a full
versus no weight-bearing status and pain among hip fracture
patients who were treated with surgery,29 although other stud-
ies have shown that no weight-bearing status is related to poor
functioning after surgery.30,31 Our findings also revealed that
patients who were able to ambulate without assistive devices
experienced more moderate-to-severe pain 2 years after hip
arthroplasty. However, these results are in contrast to some
studies that reported loss in long-term functional ability was
inversely associated with higher prefracture functional sta-
tus.31,32 These results suggest that the complex relationship
between pain and function after hip fracture surgery requires
further evaluation.
Female sex was also associated with persistent hip pain
1 year after surgery. Other researchers have reported similar
findings and have stated that female sex is related to increased
chronic pain,33,34 whereas other research has found no asso-
ciation.35 Younger ages (#79 vs. .79 years) predicted more
moderate-to-severe pain 2 years after hip arthroplasty, which
is consistent with previous studies that assessed predictors of
chronic pain after surgery.36–38 Explanations for this result
may relate to higher expectations of recovery among younger
patients or biological differences, with younger patients prob-
ably having greater neuron system responsiveness as com-
pared to older patients.39 Nevertheless, these findings differ
from some studies40,41 that failed to show age as a significant
predictor of persistent pain after surgery.
Our study has some limitations, including a high rate of
incomplete data for the outcome, especially at the 2-year
follow-up; however, our rate of missing data is consistent
with previous studies in this area.42,43 Baseline characteristics
of patients with loss to follow-up data for the outcome were
similar to patients with complete data for all significant pre-
dictors except for prefracture hip pain and functional status
related to the 24-month visit (see Table 1, Supplemental
Digital Content 1, http://links.lww.com/JOT/B205). Some
relevant comorbidities (eg, anxiety and substance use disor-
der) or the indication and dose of opioids that patients were
using before were not collected in the trial, but for future
studies, these variables should be considered. The strengths
of our study include using a large, international, representa-
tive sample that increases the generalizability of our findings,
investigating several clinically relevant independent variables




The results of this study provide insights into those at a
higher risk of having moderate-to-severe pain at one and 2
years after hip arthroplasty. Patients with prefracture hip pain,
opioid use, independent ambulatory status, female sex, and
younger ages (#79 vs. greater 79 years) are more likely to
have long-term moderate-to-severe pain after arthroplasty sur-
gery for management of femoral neck fractures. This infor-
mation will further inform health care providers and patients
and allow for better understanding of the expected benefits of
hip arthroplasty in this patient population.
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